Valuation : Stereotaxis, Inc.

Market Cap 14Cr 12Cr 11Cr 10Cr 19Cr 1.3TCr 19Cr 131.68Cr 51Cr 662.73Cr 52Cr 50Cr 2.2TCr P/E 2026 *
-6.74x
P/E 2027 * -9.34x
Enterprise Value 14Cr 12Cr 11Cr 10Cr 19Cr 1.3TCr 19Cr 131.68Cr 51Cr 662.73Cr 52Cr 50Cr 2.2TCr EV / Sales 2026 *
4x
EV / Sales 2027 * 3.01x
Free-Float
78.85%
Yield 2026 *
-
Yield 2027 * -
1 day-4.86%
1 week-2.84%
Current month-4.86%
1 month+8.73%
3 months-29.38%
6 months-36.57%
Current year-40.43%
1 week 1.35
Extreme 1.35
1.51
1 month 1.29
Extreme 1.29
1.51
Current year 1.24
Extreme 1.24
2.86
1 year 1.24
Extreme 1.24
3.59
3 years 1.24
Extreme 1.24
3.59
5 years 1.24
Extreme 1.24
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Chairman - 03/02/2017
Director/Board Member 70 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-4.86%-2.84%-52.43%-24.73% 14Cr
-2.69%-4.40%+21.87%+7.77% 22TCr
-3.10%-4.19%+0.54%-22.09% 15TCr
-2.02%-0.70%-21.98%+18.96% 13TCr
-0.46%-3.57%-54.43%-10.33% 6.97TCr
-0.01%-0.14%+11.56%+18.80% 5.23TCr
+0.43%-1.01%-17.61%-14.19% 5.07TCr
-2.36%-3.13%+19.31%+22.98% 4.23TCr
-2.12%-2.08%+34.47%+44.42% 3.99TCr
-3.64%-2.21%-15.72%+45.34% 3.34TCr
Average -1.87%-1.39%-7.44%+8.69% 7.86TCr
Weighted average by Cap. -1.64%-1.58%-0.45%+6.08%

Financials

2026 *2027 *
Net sales 3.43Cr 2.96Cr 2.79Cr 2.54Cr 4.77Cr 325.84Cr 4.8Cr 33Cr 13Cr 165.75Cr 13Cr 13Cr 549.6Cr 4.57Cr 3.94Cr 3.71Cr 3.38Cr 6.35Cr 433.41Cr 6.38Cr 44Cr 17Cr 220.46Cr 17Cr 17Cr 731.02Cr
Net income -2.01Cr -1.74Cr -1.63Cr -1.49Cr -2.8Cr -191.08Cr -2.81Cr -19Cr -7.52Cr -97Cr -7.56Cr -7.4Cr -322.29Cr -1.48Cr -1.27Cr -1.2Cr -1.09Cr -2.05Cr -140.14Cr -2.06Cr -14Cr -5.51Cr -71Cr -5.54Cr -5.42Cr -236.38Cr
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
01/26/01 $1.370 -4.86% 5,98,718
31/26/31 $1.440 -0.69% 5,93,115
28/26/28 $1.450 -1.36% 2,89,611
27/26/27 $1.470 +1.38% 4,72,972
26/26/26 $1.450 +2.84% 5,83,277
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.370USD
Average target price
3.000USD
Spread / Average Target
+118.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock